United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

500unit) powder and 10ml solvent for solution for infusion vials (takeda uk ltd - factor viii inhibitor bypassing fraction - powder and solvent for solution for infusion - 500unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

2,500unit) powder and 50ml solvent for solution for infusion vials (takeda uk ltd - factor viii inhibitor bypassing fraction - powder and solvent for solution for infusion - 2500unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bio products laboratory ltd - von willebrand factor; factor viii - powder and solvent for solution for injection - 500unit ; 250unit

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baxalta innovations gmbh - anti-inhibitor coagulant complex 500 u - powder and solvent for solution for injection - 500 u - factor viii inhibitor bypassing activity 500 iu - factor viii inhibitor bypassing activity

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baxalta innovations gmbh - anti-inhibitor coagulant complex 1000 u - powder and solvent for solution for injection - 1000 u - factor viii inhibitor bypassing activity 1000 iu - factor viii inhibitor bypassing activity

Ireland - English - HPRA (Health Products Regulatory Authority)

baxalta innovations gmbh - feiba - powder and solvent for solution for infusion - 25 unit(s)/millilitre - blood coagulation factors; factor viii inhibitor bypassing activity - coagulation factors - it is used for: treatment of bleeding in hemophilia a patients with inhibitors; treatment of bleeding in hemophilia b patients with inhibitors, if no other specific treatment is available (see section 5.1); treatment of bleeding in non-hemophiliacs with acquired inhibitors to factor viii; prophylaxis of bleeding in hemophilia a patients with inhibitors who have experienced a significant bleed or are at high risk of significant bleeding

Ireland - English - HPRA (Health Products Regulatory Authority)

baxalta innovations gmbh - feiba - powder and solvent for solution for infusion - 50 unit(s)/millilitre - blood coagulation factors; factor viii inhibitor bypassing activity - blood coagulation factors - it is used for: treatment of bleeding in hemophilia a patients with inhibitors; treatment of bleeding in hemophilia b patients with inhibitors, if no other specific treatment is available (see section 5.1); treatment of bleeding in non-hemophiliacs with acquired inhibitors to factor viii; prophylaxis of bleeding in hemophilia a patients with inhibitors who have experienced a significant bleed or are at high risk of significant bleeding

Namibia - English - Namibia Medicines Regulatory Council

adcock ingram critical care (pty) ltd - factor viii inhibitor - injection - each 1 ml solution contains: factor viii inhibitor bypassing activity 50 u

Namibia - English - Namibia Medicines Regulatory Council

adcock ingram critical care (pty) ltd - factor viii inhibitor - injection - each 1 ml solution contains: factor viii inhibitor bypassing activity 50 iu

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn. bhd. - human coagulation factor viii; von willebrand factor -